Non-canonical chemical feedback self-limits nitric oxide-cyclic GMP signaling in health and disease
Open Access
- 19 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 10 (1), 1-10
- https://doi.org/10.1038/s41598-020-66639-w
Abstract
Nitric oxide (NO)-cyclic GMP (cGMP) signaling is a vasoprotective pathway therapeutically targeted, for example, in pulmonary hypertension. Its dysregulation in disease is incompletely understood. Here we show in pulmonary artery endothelial cells that feedback inhibition by NO of the NO receptor, the cGMP forming soluble guanylate cyclase (sGC), may contribute to this. Both endogenous NO from endothelial NO synthase and exogenous NO from NO donor compounds decreased sGC protein and activity. This effect was not mediated by cGMP as the NO-independent sGC stimulator, or direct activation of cGMP-dependent protein kinase did not mimic it. Thiol-sensitive mechanisms were also not involved as the thiol-reducing agent N-acetyl-L-cysteine did not prevent this feedback. Instead, both in-vitro and in-vivo and in health and acute respiratory lung disease, chronically elevated NO led to the inactivation and degradation of sGC while leaving the heme-free isoform, apo-sGC, intact or even increasing its levels. Thus, NO regulates sGC in a bimodal manner, acutely stimulating and chronically inhibiting, as part of self-limiting direct feedback that is cGMP independent. In high NO disease conditions, this is aggravated but can be functionally recovered in a mechanism-based manner by apo-sGC activators that re-establish cGMP formation.This publication has 85 references indexed in Scilit:
- Soluble guanylyl cyclase requires heat shock protein 90 for heme insertion during maturation of the NO-active enzymeProceedings of the National Academy of Sciences of the United States of America, 2012
- Intracellular Nitric Oxide Mediates Neuroproliferative Effect of Neuropeptide Y on Postnatal Hippocampal Precursor CellsOnline Journal of Public Health Informatics, 2012
- Translating the oxidative stress hypothesis into the clinic: NOX versus NOSJournal of Molecular Medicine, 2009
- Cyclic GMP signaling in cardiovascular pathophysiology and therapeuticsPharmacology & Therapeutics, 2009
- Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation‐induced degradationBritish Journal of Pharmacology, 2009
- Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclaseBritish Journal of Pharmacology, 2008
- The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troublesBritish Journal of Pharmacology, 2008
- iNOS expression requires NADPH oxidase‐dependent redox signaling in microvascular endothelial cellsJournal of Cellular Physiology, 2008
- Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylationProceedings of the National Academy of Sciences of the United States of America, 2007
- NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialNature Reviews Drug Discovery, 2006